Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.35 |
| ▸ | DNTT | P04053 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | POLA1 | P09884 | 1/20 | 0.30 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31186272 | 0.98 | PTPN1 (0.37) | PTPN1DNTTPOLBPOLA1OPRM1 | |
| SCHEMBL9741366 | 0.98 | PTPN1 (0.37) | PTPN1DNTTPOLBPOLA1OPRM1 | |
| SCHEMBL28810974 | 0.98 | PTPN1 (0.37) | PTPN1DNTTPOLBPOLA1OPRM1 | |
| SCHEMBL31186294 | 0.98 | PTPN1 (0.37) | PTPN1DNTTPOLBPOLA1OPRM1 | |
| SCHEMBL31186400 | 0.98 | PTPN1 (0.37) | PTPN1DNTTPOLBPOLA1OPRM1 | |
| SCHEMBL2689799 | 0.98 | PTPN1 (0.37) | PTPN1DNTTPOLBPOLA1OPRM1 | |
| SCHEMBL28305096 | 0.98 | PTPN1 (0.37) | PTPN1DNTTPOLBPOLA1OPRM1 | |
| SCHEMBL27916243 | 0.79 | PTPN1 (0.33) | PTPN1DNTTPOLBPOLA1OPRM1 | |
| SCHEMBL11582079 | 0.77 | — | — | |
| SCHEMBL28827891 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3291807-B1 | HYDROGENATION OF CANNABIS OIL | SCIALDONE MARK ANDREW (US) | 2019-09-25 | — | — | EP | disclosed |
| US-20190030102-A1 | HYDROGENATION OF CANNABIS OIL | RESEARCH GROW LABS | 2019-01-31 | — | — | US | disclosed |
| US-9694040-B2 | Hydrogenation of cannabis oil | RESEARCH GROW LABS | 2017-07-04 | — | — | US | disclosed |
| US-20160324909-A1 | HYDROGENATION OF CANNABIS OIL | RESEARCH GROW LABS | 2016-11-10 | — | — | US | disclosed |
| US-20080275237-A1 | Method for Obtaining Pure Tetrahydrocannabinol | PURISYS LLC | 2008-11-06 | — | — | US | disclosed |
| EP-1773801-A1 | METHOD FOR OBTAINING PURE TETRAHYDROCANNABINOL | Cilag Ltd. (CH) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006007734-A1 | METHOD FOR OBTAINING PURE TETRAHYDROCANNABINOL | CILAG LTD. (CH) | 2006-01-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275237-A1 | Method for Obtaining Pure Tetrahydrocannabinol | CNR2, CNR1, CETP | PTPN1 4469/4885DNTT 1564/4885POLB 2464/4885 |
| US-20190030102-A1 | HYDROGENATION OF CANNABIS OIL | CNR2, CNR1, HHAT | PTPN1 4707/4885DNTT 2183/4885POLB 1286/4885 |
| US-20160324909-A1 | HYDROGENATION OF CANNABIS OIL | CNR2, CNR1, HHAT | PTPN1 4707/4885DNTT 2183/4885POLB 1286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.